Oruka Therapeutics Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| FMR LLC | 05/15/2026 | 7.43 M | $364.51 M | 2.34% | 16.29% |
| VR ADVISER, LLC | 05/15/2026 | 4.15 M | $203.48 M | 0.00% | 9.09% |
| FAIRMOUNT FUNDS MANAGEMENT LLC | 05/15/2026 | 3.71 M | $181.74 M | 0.00% | 8.12% |
| BLACKROCK, INC. | 05/13/2026 | 3.53 M | $173.00 M | -0.35% | 7.73% |
| VIKING GLOBAL INVESTORS LP | 05/15/2026 | 2.67 M | $130.80 M | 0.00% | 5.85% |
| PARADIGM BIOCAPITAL ADVISORS LP | 05/15/2026 | 2.32 M | $113.81 M | 35.67% | 5.09% |
| RTW INVESTMENTS, LP | 05/15/2026 | 2.06 M | $100.95 M | 0.00% | 4.51% |
| DEEP TRACK CAPITAL, LP | 05/15/2026 | 2.03 M | $99.78 M | -5.89% | 4.46% |
| 05/15/2026 | 1.86 M | $91.21 M | 100.00% | 4.08% | |
| STATE STREET CORP | 05/15/2026 | 1.61 M | $79.14 M | 16.59% | 3.54% |
| 05/19/2026 | 1.57 M | $76.80 M | 0.85% | 3.43% | |
| PERCEPTIVE ADVISORS LLC | 05/29/2026 | 1.40 M | $68.45 M | -5.49% | 3.06% |
| POLAR CAPITAL HOLDINGS PLC | 05/15/2026 | 1.05 M | $51.39 M | 7.09% | 2.30% |
| CITADEL ADVISORS LLC | 05/15/2026 | 1.01 M | $49.42 M | 38.76% | 2.21% |
| FRANKLIN RESOURCES INC | 05/13/2026 | 1.00 M | $49.25 M | 6.99% | 2.20% |
| GEODE CAPITAL MANAGEMENT, LLC | 05/15/2026 | 954.87 K | $46.85 M | 1.31% | 2.09% |
| MERCER GLOBAL ADVISORS INC /ADV | 05/15/2026 | 802.47 K | $39.36 M | 7.67% | 1.76% |
| AVIDITY PARTNERS MANAGEMENT LP | 05/28/2026 | 760.42 K | $37.30 M | 15.14% | 1.67% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 05/15/2026 | 727.45 K | $35.68 M | 12.03% | 1.59% |
| WOODLINE PARTNERS LP | 05/15/2026 | 574.88 K | $28.20 M | 0.06% | 1.26% |
| CORMORANT ASSET MANAGEMENT, LP | 05/15/2026 | 533.34 K | $26.16 M | 0.00% | 1.17% |
| BELLEVUE GROUP AG | 05/15/2026 | 507.01 K | $24.87 M | 100.00% | 1.11% |
| AFFINITY ASSET ADVISORS, LLC | 05/14/2026 | 499.67 K | $24.51 M | -37.72% | 1.10% |
| SYNERGY ASSET MANAGEMENT, LLC | 05/13/2026 | 476.20 K | $23.36 M | 3.76% | 1.04% |
| SR ONE CAPITAL MANAGEMENT, LP | 05/14/2026 | 430.33 K | $21.11 M | 0.00% | 0.94% |
| CANDRIAM S.C.A. | 04/30/2026 | 411.01 K | $20.16 M | 2.62% | 0.90% |
| 05/08/2026 | 350.89 K | $17.21 M | 100.00% | 0.77% | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 05/15/2026 | 321.95 K | $15.79 M | -2.29% | 0.71% |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 05/11/2026 | 313.13 K | $15.36 M | 100.00% | 0.69% |
| NORTHERN TRUST CORP | 05/14/2026 | 299.04 K | $14.67 M | 6.46% | 0.66% |
| VANGUARD FIDUCIARY TRUST CO | 05/08/2026 | 257.07 K | $12.61 M | 100.00% | 0.56% |
| GOLDMAN SACHS GROUP INC | 05/15/2026 | 246.71 K | $12.10 M | 165.29% | 0.54% |
| IKARIAN CAPITAL, LLC | 05/15/2026 | 242.02 K | $11.87 M | 100.00% | 0.53% |
| ATIKA CAPITAL MANAGEMENT LLC | 05/14/2026 | 229.90 K | $11.28 M | 100.00% | 0.50% |
| UBS GROUP AG | 05/05/2026 | 212.27 K | $10.41 M | -21.68% | 0.47% |
| CABLE CAR CAPITAL LLC | 05/15/2026 | 200.00 K | $9.81 M | -50.00% | 0.44% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 05/15/2026 | 190.03 K | $9.32 M | 100.00% | 0.42% |
| HOLOCENE ADVISORS, LP | 05/15/2026 | 185.51 K | $9.10 M | 100.00% | 0.41% |
| ALYESKA INVESTMENT GROUP, L.P. | 05/15/2026 | 184.86 K | $9.07 M | 84.86% | 0.41% |
| GREAT POINT PARTNERS LLC | 05/15/2026 | 183.33 K | $8.99 M | 0.00% | 0.40% |
| JENNISON ASSOCIATES LLC | 05/06/2026 | 176.68 K | $8.67 M | 100.00% | 0.39% |
| MORGAN STANLEY | 05/15/2026 | 175.45 K | $8.61 M | 43.58% | 0.38% |
| PFM HEALTH SCIENCES, LP | 05/15/2026 | 174.05 K | $8.54 M | 100.00% | 0.38% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 05/14/2026 | 150.91 K | $7.40 M | 100.00% | 0.33% |
| 05/14/2026 | 140.84 K | $6.91 M | 100.00% | 0.31% | |
| DEUTSCHE BANK AG\ | 05/06/2026 | 140.79 K | $6.91 M | 17.98% | 0.31% |
| LONGAEVA PARTNERS L.P. | 05/15/2026 | 136.88 K | $6.71 M | 6.85% | 0.30% |
| MOODY ALDRICH PARTNERS LLC | 04/20/2026 | 135.06 K | $6.62 M | 6.50% | 0.30% |
| SIO CAPITAL MANAGEMENT, LLC | 05/14/2026 | 132.50 K | $6.50 M | 12.17% | 0.29% |
| KENNEDY CAPITAL MANAGEMENT LLC | 05/13/2026 | 126.37 K | $6.20 M | 159.55% | 0.28% |
Oruka Therapeutics Inc. institutional Ownership - FAQ's
During the previous two years, 197 institutional investors and hedge funds held shares of Oruka Therapeutics Inc.. The most heavily invested institutionals were:
FMR LLC: 7.43 M
VR Adviser, LLC: 4.15 M
Fairmount Funds Management LLC: 3.71 M
BlackRock, Inc.: 3.53 M
VIKING GLOBAL INVESTORS LP: 2.67 M
Paradigm Biocapital Advisors LP: 2.32 M
114.04% of Oruka Therapeutics Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 50.50 M shares in the last 24 months. This purchase volume represents approximately $1.70 B in transactions.